The Daily Overview on MSN
Eli Lilly closes in on a deal to buy biotech Ventyx
Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...
With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...
24/7 Wall St. on MSN
Biotech could be one of 2026’s biggest winners, and this ETF is perfectly positioned
Quick Read FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast ...
Alliance brings together complementary strengths in commercialization strategy, cross-functional launch readiness, ...
Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz Supply / Biotech Labz Supply has revealed an exciting enhancement of its ...
Biotech shares have fallen while cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás ...
It sounds like Lilly did just that. The U.S. pharma announced Wednesday that it was paying $14 per share of Ventyx—more than ...
For the third year in a row, Fierce Biotech’s Layoff Tracker is topping the tree as the story with the highest number of ...
A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...
A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...
O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics ( NTLA ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback